How Long Does LPP Treatment Take to Work? Measuring Response
At a Glance
Lichen planopilaris treatment is usually assessed over months: an early review may occur at 2–3 months, while meaningful control often takes 3–6 months and some medicines up to 6–12 months. Dermatologists track inflammation and shedding with scalp exams, magnified views, photos, and scoring.
In this answer
3 sections
When you start treatment for lichen planopilaris (LPP), improvement is usually gradual. While timelines vary by the person and the specific medication, it typically takes 2 to 3 months for an initial check-in [1][2]. This early visit is often to ensure the medication is safe, check for side effects, and see if symptoms like itching or burning are improving. It generally takes 3 to 6 months for a meaningful reassessment of whether the disease’s physical activity has slowed down [1][2]. Some systemic medications (drugs taken by mouth or injection that affect the whole body), such as hydroxychloroquine, may take 6 to 12 months to reach their maximum benefit [3].
Because LPP damages the hair follicles and can cause permanent scarring, the primary goal of treatment is to stop or slow the progression of the disease—not necessarily to regrow hair in already scarred areas, though regrowth may occur where follicles remain viable [4][1].
What to Expect During Treatment
Treatment for LPP requires patience and long-term management. Because the disease course is unpredictable, there is no guaranteed timetable for remission (which means halting active inflammation and progression, not necessarily regrowing lost hair) [5][6].
- Early signs (weeks to a few months): Relief from symptoms like itching, pain, tenderness, and burning often happens first [2][7]. However, symptoms are an imperfect measure; active disease and hair loss can continue even when your scalp feels better [8].
- Mid-term signs (3 to 6 months): You and your doctor may see a reduction in visible inflammation, such as scaling and redness around the hair follicles, and a slowing of active hair shedding or disease spread [2][9].
- Long-term control (6 to 12+ months): The goal is stable disease. While some treatments, like topical clobetasol, can show improvements by 2 months, patients require ongoing monitoring because inflammation and hair loss can return [10]. Some people achieve control within months, while others need prolonged therapy [5].
How Clinicians Measure Success
Dermatologists use several tools to track whether your treatment is working. Relying on how your scalp feels is not enough, as active hair loss can continue even when symptoms stop [8].
- Lichen Planopilaris Activity Index (LPPAI): This is a structured scoring system that combines your symptoms, physical signs, and a clinician-performed “hair pull test” to see if active hair shedding is occurring [11]. A dropping score is useful evidence that treatment is working, but it must be interpreted alongside other signs, as not every clinic uses this exact score [2].
- Trichoscopy: Your dermatologist uses a magnifying tool with a light to examine your scalp. They look for specific signs of active LPP, such as perifollicular erythema (redness around the base of the hair follicle) and perifollicular scale (flaking tightly wrapped around the hair shaft) [11][12].
- Serial Photography: Standardized photos of your scalp and hairline allow your doctor to compare your baseline appearance to follow-up visits [12][13]. Consistent lighting and hair parting improve these comparisons.
- Hair Measurements: Sometimes tools like a phototrichogram (specialized digital photos to count and measure hairs) are used [14]. Importantly, underlying inflammation can improve even if hair density does not immediately change [14].
Safety, Side Effects, and Following the Plan
Because it takes months to gauge whether a medication is controlling your LPP, you should generally not stop or change your treatment just because you don’t see instant hair regrowth [1].
Important Safety Note: This advice does not apply to side effects. If you experience concerning medication side effects, contact your prescriber promptly. Do not wait for your next scheduled review. Furthermore, some LPP medications require specific safety monitoring—for example, hydroxychloroquine requires regular eye exams and lab tests [15][2]. Follow your doctor’s safety guidelines strictly.
If your bald patches are rapidly expanding despite treatment, contact your doctor sooner. They may need to reassess the diagnosis and activity, and discuss adjusting or combining treatments to prevent permanent follicular damage [1][4].
When preparing for your follow-up visits, it helps to bring a list of all your current medications, notes on any new areas of shedding or changes in itching, and consistent home photos if your clinician recommends them.
Common questions in this guide
How long does it usually take for lichen planopilaris treatment to start working?
What are the first signs that LPP treatment is working?
How do dermatologists measure whether LPP treatment is working?
Can lichen planopilaris treatment regrow hair that has already been lost?
Should I stop LPP treatment if I do not see hair regrowth right away?
What safety monitoring may be needed for lichen planopilaris medicines?
Related questions
Show more
Get notified when new evidence is published on Lichen planopilaris.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Management of classic lichen planopilaris: The EADV task force on hair diseases position statement.
Seyed Jafari SM, Starace M, Katoulis A, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2026; (40(8)):1306-1317 doi:10.1111/jdv.70379.
PMID: 41848299 - 2
Clinical Efficacy and Safety of Methotrexate versus Hydroxychloroquine in Preventing Lichen Planopilaris Progress: A Randomized Clinical Trial.
Naeini FF, Saber M, Asilian A, Hosseini SM
International journal of preventive medicine 2017; (8()):37 doi:10.4103/ijpvm.IJPVM_156_17.
PMID: 28584619 - 3
The efficacy of antimalarial drugs in the therapy of selected forms of cicatricial alopecia.
Zbiciak-Nylec MA, Brzezińska-Wcisło L, Salwowska N
Postepy dermatologii i alergologii 2021; (38(2)):302-309 doi:10.5114/ada.2021.106208.
PMID: 34408598 - 4
Lichen Planopilaris in Children: A Systematic Review.
Papierzewska M, Waśkiel-Burnat A, Rudnicka L
Pediatric dermatology 2025; (42(1)):22-30 doi:10.1111/pde.15835.
PMID: 39629624 - 5
Exploring Remission Dynamics and Prognostic Factors in Lichen Planopilaris: A Retrospective Cohort Study.
Lyakhovitsky A, Zilbermintz T, Segal Z, et al.
Dermatology (Basel, Switzerland) 2024; (240(4)):531-542 doi:10.1159/000538355.
PMID: 38574470 - 6
Lichen Planopilaris in Women: A Retrospective Review of 232 Women Seen at Mayo Clinic From 1992 to 2016.
Larkin SC, Cantwell HM, Imhof RL, et al.
Mayo Clinic proceedings 2020; (95(8)):1684-1695 doi:10.1016/j.mayocp.2020.02.028.
PMID: 32753140 - 7
A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris.
Svigos K, Yin L, Fried L, et al.
American journal of clinical dermatology 2021; (22(5)):681-692 doi:10.1007/s40257-021-00630-7.
PMID: 34347282 - 8
Diffuse Lichen Planopilaris Masquerading as Diffuse Alopecia Areata.
Yoo LJH, Meah N, Wall D, McDonald I
Case reports in dermatology 2024; (16(1)):83-87 doi:10.1159/000538064.
PMID: 38529513 - 9
Treatment of lichen planopilaris: methotrexate or cyclosporine a therapy?
Bulbul Baskan E, Yazici S
Cutaneous and ocular toxicology 2018; (37(2)):196-199 doi:10.1080/15569527.2017.1382503.
PMID: 28944688 - 10
Platelet-rich plasma as a new and successful treatment for lichen planopilaris: A controlled blinded randomized clinical trial.
Behrangi E, Akbarzadehpasha A, Dehghani A, et al.
Journal of cosmetic dermatology 2024; (23(8)):2547-2555 doi:10.1111/jocd.16302.
PMID: 38525908 - 11
Assessing the correlation between trichoscopic features in lichen planopilaris and lichen planopilaris activity index.
Lajevardi V, Mahmoudi H, Moghanlou S, et al.
The Australasian journal of dermatology 2019; (60(3)):214-218 doi:10.1111/ajd.13022.
PMID: 30957880 - 12
Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features.
Fechine COC, Valente NYS, Romiti R
Anais brasileiros de dermatologia 2022; (97(3)):348-357 doi:10.1016/j.abd.2021.08.008.
PMID: 35379508 - 13
Comparative Efficacy Study Combination of Oral Methotrexate and Prednisolone versus Oral Methotrexate in Patients with Lichen Planopilaris.
Fatemi F, Esfahanian F, Asilian A, et al.
Dermatology research and practice 2022; (2022()):3792489 doi:10.1155/2022/3792489.
PMID: 36254319 - 14
Valchlor® in the Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Single Arm, Open-label, Exploratory Study.
Pincelli TP, Heckman MG, Cochuyt JJ, Sluzevich JC
International journal of trichology 2020; (12(5)):220-226 doi:10.4103/ijt.ijt_16_20.
PMID: 33531744 - 15
[Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19].
Morgado-Carrasco D, Ibaceta-Ayala J, Piquero-Casals J
Actas dermo-sifiliograficas 2022; (113(2)):166-175 doi:10.1016/j.ad.2021.07.005.
PMID: 34366433
This page is for informational purposes only and does not constitute medical advice about lichen planopilaris treatment. Your dermatologist or prescriber should interpret your response and advise you about side effects, monitoring, and medication changes.